abstract |
The present invention relates to an anti-CD300c monoclonal antibody, and a use thereof for preventing or treating cancer. The anti-CD300c monoclonal antibody according to the present invention binds to a CD300c antigen while having high specificity, and promotes anticancer immune activity, and thus is expected to be effectively used against the growth, development, and metastasis of varieties of cancer. |